Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TMDX | Common Stock | Options Exercise | $22K | +1.36K | +9.65% | $16.14* | 15.5K | Feb 1, 2023 | Direct | F1 |
transaction | TMDX | Common Stock | Options Exercise | $1.81K | +47 | +0.3% | $38.46 | 15.5K | Feb 1, 2023 | Direct | F1 |
transaction | TMDX | Common Stock | Sale | -$36.1K | -582 | -3.75% | $62.00 | 14.9K | Feb 1, 2023 | Direct | F1, F2 |
transaction | TMDX | Common Stock | Sale | -$23.7K | -379 | -2.54% | $62.52 | 14.6K | Feb 1, 2023 | Direct | F1, F3 |
transaction | TMDX | Common Stock | Sale | -$6.15K | -96 | -0.66% | $64.04 | 14.5K | Feb 1, 2023 | Direct | F1, F4 |
transaction | TMDX | Common Stock | Sale | -$9.02K | -139 | -0.96% | $64.88 | 14.3K | Feb 1, 2023 | Direct | F1, F5 |
transaction | TMDX | Common Stock | Sale | -$14.1K | -214 | -1.49% | $65.81 | 14.1K | Feb 1, 2023 | Direct | F1, F6 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TMDX | Stock Option (Right to Buy) | Options Exercise | $0 | -1.36K | -21.81% | $0.00 | 4.89K | Feb 1, 2023 | Common Stock | 1.36K | $16.14 | Direct | F1, F7 |
transaction | TMDX | Stock Option (Right to Buy) | Options Exercise | $0 | -47 | -0.35% | $0.00 | 13.5K | Feb 1, 2023 | Common Stock | 47 | $38.46 | Direct | F1, F8 |
John F. Carey is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Id | Content |
---|---|
F1 | The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. |
F2 | The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.23 to $62.22, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
F3 | The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.23 to $63.02, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
F4 | The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $63.43 to $64.41, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
F5 | The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $64.45 to $65.42, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
F6 | The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $65.45 to $65.96, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
F7 | The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. |
F8 | The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. |
The reporting person is no longer subject to Section 16 in connection with his transactions in securities of the Company and therefore will no longer report any such transactions on Form 4 or Form 5.